A2 Healthcare Taiwan Corporation

Abiogenesis Clinpharm Private Limited is an emerging contract research organization (CRO) that provides client specific services in clinical development of drugs and devices. Our research wing helps clients in clinical development program of drugs and devices at every step. Our expertise comes from an experienced team of professionals having credentials of successfully conducting national and international clinical trials across all phases of clinical development. Abiogenesis Clinpharm Private Limited is capable of delivering quality work from early proof of concept to late phase development including post launch product lifecycle management.

We are a team of highly skilled people having expertise in the area of clinical research and work experience in leading clinical development programs of many reputed organizations. Our team epitomise scientific knowledge and operational excellence in clinical research industry. We have the ability to integrate the primary concept of clinical development into project management plan with micro level execution strategies. We have direct operating experience from initial planning to project execution from Phase I to Phase IV studies in different therapeutic areas across the globe. Our expertise should be utilised in following services.

• Clinical Operation
• Biometrics
• Regulatory Affairs
• Medical Affairs
• Quality Assurance
• Pharmacovigilance

ACROSS is the first truly global, agile CRO alliance. Offering cost effective, cutting edge innovative solutions for small/medium pharmaceutical and biotech companies as well as public health institutes and non-governmental organizations, ACROSS is the latest player on the global field of clinical trials.

ACROSS Global is an entirely new business model, providing enhanced and innovative global solutions through highly qualified, globally experienced, knowledgeable local experts. ACROSS Global identifies, analyses and mitigates risks across the entire clinical research spectrum, with an agility and focus to the envy of competitors. We provide value added solutions individually tailored for small and mid-size companies.

Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health.

Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.

At Aragen, we recognize your work is vital, urgent and impacts lives. Our purpose, ‘In every molecule is the possibility for better health’ motivates us to drive the success of your programs, so that we can together transform hope into health for millions of people around the world.

Asiatic aims to be a pioneer in emerging as one of India's first hybrid CRO that integrates technology and nurtures captive sites from tier II/III cities to bring a larger pool of investigators and patients into the clinical research world that would enable quicker new drug development.

AXIS Clinicals Limited is one of the most experienced and fastest growing Clinical Research Organization.

Our state-of-the-art facilities houses 500+ dedicated full-time professionals to ensure the quick turn around time with high quality. Our facilities are accredited by DCGI (Drugs Controller General – India), NABL (National Accreditation Board for Testing and Calibration Laboratories - ISO 15189:2003) and inspected by US-FDA, UK-MHRA, Brazil-ANVISA, France –AFSSAPS / ANSM, GCC, MCC-South Africa etc.

Within short span, we have achieved the milestone of completing 2750+ clinical studies and 1000+ product approvals from various regulatory agencies.

65+ regulatory audits from global competent authorities is testament to our professionalism and dedication to quality studies.

Our Phase II – IV capabilities are growing along with an extended portfolio of Site Management, Medical Writing, and Data Management.